Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.30

ANIP Q3 2016 Earnings — ANI Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

ANIPANI Pharmaceuticals, Inc.

$2B

Q3 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$39M

Gross Profit

$22M56.7% margin

Operating Income

$8M20.6% margin

Net Income

$3M6.6% margin

EPS (Diluted)

$0.22

QoQ Revenue Growth

+22.9%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

-$5,000

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$319M

Total Liabilities

$151M

Stockholders' Equity

$169M

Cash & Equivalents

$16M

Revenue Segments

Unapproved Products

$5,000100%

← FY 2016 All Quarters Q4 2016 →